JPH09121877A - Production of highly pure l-lactic acid with bacillus group microorganism - Google Patents

Production of highly pure l-lactic acid with bacillus group microorganism

Info

Publication number
JPH09121877A
JPH09121877A JP28066095A JP28066095A JPH09121877A JP H09121877 A JPH09121877 A JP H09121877A JP 28066095 A JP28066095 A JP 28066095A JP 28066095 A JP28066095 A JP 28066095A JP H09121877 A JPH09121877 A JP H09121877A
Authority
JP
Japan
Prior art keywords
bacillus
lactic acid
optical purity
microorganism
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP28066095A
Other languages
Japanese (ja)
Other versions
JP3736691B2 (en
Inventor
Hitomi Obara
仁実 小原
Masahito Yahata
雅人 矢幡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shimadzu Corp
Original Assignee
Shimadzu Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shimadzu Corp filed Critical Shimadzu Corp
Priority to JP28066095A priority Critical patent/JP3736691B2/en
Priority to BR9605262A priority patent/BR9605262A/en
Priority to US08/738,289 priority patent/US5801025A/en
Priority to CN96121927A priority patent/CN1075111C/en
Priority to EP96117295A priority patent/EP0770684B1/en
Priority to ES96117295T priority patent/ES2188708T3/en
Publication of JPH09121877A publication Critical patent/JPH09121877A/en
Priority to CN00133110A priority patent/CN1308128A/en
Application granted granted Critical
Publication of JP3736691B2 publication Critical patent/JP3736691B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To profitably obtain the subject compound useful for producing biodegradable resins, foods, medicines, optical materials, etc., by culturing a Bacillus group microorganism having an ability to produce the highly optically pure L-lactic acid from a carbon source capable of being assimilated and subsequently collecting the product from the culture product. SOLUTION: A microorganism, such as Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis, Bacillus larvae, Bacillus lentimorbus, Bacillus popilliae or Bacillus sphaericus, having an ability to produce L-lactic acid having an optical purity of >=70% from a carbon source capable of being assimilated is cultured, and the product is collected from the culture products to obtain the objective highly pure L-lactic acid at a low cost.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、バチルス属の特定
種微生物を用いた高純度L−乳酸の製造方法に関し、よ
り詳しくは、高純度L−乳酸を安価に製造する方法に関
する。また、本発明は、バチルス属の特定種微生物を用
いて高純度L−乳酸と殺虫性毒素とを同時に製造する方
法にも関する。
TECHNICAL FIELD The present invention relates to a method for producing high-purity L-lactic acid using a microorganism of the genus Bacillus, and more particularly to a method for producing high-purity L-lactic acid at low cost. The present invention also relates to a method for simultaneously producing high-purity L-lactic acid and an insecticidal toxin using a microorganism of the genus Bacillus.

【0002】[0002]

【従来の技術】L−乳酸は、生分解性プラスチックであ
るポリ乳酸の原料、食品、医薬品、醸造、皮なめし、光
学材料等に用いられる。また、殺虫性毒素は、従来の農
薬と異なり、人畜に無害な農薬として注目されているも
のである。
L-lactic acid is used as a raw material for polylactic acid which is a biodegradable plastic, food, medicine, brewing, tanning and optical materials. Further, unlike conventional pesticides, insecticidal toxins are attracting attention as pesticides that are harmless to humans and animals.

【0003】乳酸をポリ乳酸の原料として用いる場合、
光学純度の高い乳酸を原料とする方が、結晶性の高いポ
リマーが得られる。このことは例えば、Kulkarni,R.K.,
Moore,E.G., Hegyeli,A.F., and Leonard,F. (1971) B
iodegradable poly(lactic acid)polymers. J. Biomed.
Mater. Res.(ジャーナル オブ バイオメディカルマ
テリアル リサーチ),5:169-181.や、Ohara,H. (199
4) Poly-L-Lactic acid as biodegradable plastic. Bi
osci. Indust.(バイオサイエンスとインダストリ
ー),52:642-644. に記載されている。そして、結晶性
の高いポリ乳酸は、延伸フィルム、紡糸に適している。
When lactic acid is used as a raw material for polylactic acid,
A polymer having higher crystallinity can be obtained by using lactic acid having a high optical purity as a raw material. This means, for example, Kulkarni, RK,
Moore, EG, Hegyeli, AF, and Leonard, F. (1971) B
iodegradable poly (lactic acid) polymers. J. Biomed.
Mater. Res. (Journal of Biomedical Materials Research), 5: 169-181. And Ohara, H. (199
4) Poly-L-Lactic acid as biodegradable plastic. Bi
osci. Indust. (Bioscience and Industry), 52: 642-644. Polylactic acid having high crystallinity is suitable for stretched films and spinning.

【0004】また、高純度L−乳酸は液晶に使用可能で
あり、例えば、Sato,k., Eguchi,T., Toshida,y., Yosh
inaga,K., and Takasu,Y. (1990) Properties of the f
erroelectric polymer liquid crystals containing a
chiral lactic acid derivative group. Polymer prepr
ints, Japan,(高分子化学大会予稿集)39:1962-1964.
や、Yoshinaga,K., Eguchi,T., Sato,K., Toshida,Y.,
and Takasu,Y. (1990)Properties of the ferroelectri
c polymer liquid crystals containing a chiral lact
ic acid derivative group(II). Polymer preprings, J
apan,(高分子化学大会予稿集)39:1962-1964. に記載
されている。
Further, high-purity L-lactic acid can be used in liquid crystals, for example, Sato, k., Eguchi, T., Toshida, y., Yosh.
inaga, K., and Takasu, Y. (1990) Properties of the f
erroelectric polymer liquid crystals containing a
chiral lactic acid derivative group. Polymer prepr
ints, Japan, (Polymer Chemistry Conference Proceedings) 39: 1962-1964.
And Yoshinaga, K., Eguchi, T., Sato, K., Toshida, Y.,
and Takasu, Y. (1990) Properties of the ferroelectri
c polymer liquid crystals containing a chiral lact
ic acid derivative group (II). Polymer preprings, J
apan, (Polymer Chemistry Conference Proceedings) 39: 1962-1964.

【0005】さらに、FAO (国連食糧農業機関)とWHO
(世界保健機関)は、乳幼児に与える乳酸はL−乳酸で
あることが好ましいとしている。このことは、FAO and
WHO(1974) Toxicological evaluation of certain food
additives with a reviewof general principles and
of specifications. World Health Organization,Genev
a,p23. に記載されている。
Furthermore, FAO (United Nations Food and Agriculture Organization) and WHO
The (World Health Organization) prefers that lactic acid given to infants is L-lactic acid. This is FAO and
WHO (1974) Toxicological evaluation of certain food
additives with a review of general principles and
of specifications. World Health Organization, Genev
a, p23.

【0006】このように、L−乳酸は有用であり、しか
も高純度であることが要求されている。
Thus, L-lactic acid is required to be useful and highly pure.

【0007】従来より、発酵によりL−乳酸を製造する
方法が知られている。例えば、(1) ストレプトコッカス
フェカリス(Streptococcus faecalis)を用いたL−乳
酸の製造が、Ohara,H., Hiyama,K., and Yoshida,T. (1
993) Lactic acid production by a filter-bed-type r
eactor. J. Ferment. Bioeng. (ジャーナルオブ ファ
ーメンテーション アンド バイオエンジニアリング)
76:73-75. に記載され、(2) ラクトバチルス ヘルベテ
ィクス(Lactobacillus helvetics) を用いたL−乳酸の
製造が、Aeschlimann,A., Di Stasei,L., and von Stoc
kar,U. Continuous production of lactic acid from w
hey permeate by Lactobacillus helvetics in two che
mostats in series. Enzyme Microbiol. Technol. (エ
ンザイムマイクロバイオロジー アンド テクノロジ
ー)12:926-932. に記載され、(3) ラクトバチルス ア
ミロボラス(Lactobacillus amylovorus)を用いたL−乳
酸の製造が、Nakamura,L.K. and Crowell C.D. (1979)
Lactobacillus amylovorus, a new starch-hydrolyzing
species from swine waste-com fermentation. Div. I
nd. Microbiol. 20:531-540.に記載され、(4) ラクトバ
チルス デルブルッキー(Lactobacillus delbruekii)を
用いたL−乳酸の製造が、Stenroos,S.L., Linko,Y.Y.,
and Linko,P. (1982) Production of L-lactic acid w
ith immobilized Lactobacillus delbruekii. Bacterio
l.Lett.(バイオテクノロジーレター)4:159-164.に記
載され、(5) ラクトコッカス ラクティス(Lactococcus
lactis)を用いたL−乳酸の製造が、Ishizaki,A. and
Kobayashi,G. (1990) Computer simulation of L-lacta
te batch fermentation applying the enzyme inactiva
tion scheme. J. Ferment. Bioeng. 70:139-140.に記載
されている。
Conventionally, a method of producing L-lactic acid by fermentation has been known. For example, (1) Production of L-lactic acid using Streptococcus faecalis is described in Ohara, H., Hiyama, K., and Yoshida, T. (1).
993) Lactic acid production by a filter-bed-type r
eactor. J. Ferment. Bioeng. (Journal of Fermentation and Bioengineering)
76: 73-75., (2) Production of L-lactic acid using Lactobacillus helvetics, Aeschlimann, A., Di Stasei, L., and von Stoc.
kar, U. Continuous production of lactic acid from w
hey permeate by Lactobacillus helvetics in two che
Mostats in series. Enzyme Microbiol. Technol. (Enzyme Microbiology and Technology) 12: 926-932., (3) L-lactic acid production using Lactobacillus amylovorus is described in Nakamura, LK. and Crowell CD (1979)
Lactobacillus amylovorus, a new starch-hydrolyzing
species from swine waste-com fermentation. Div. I
nd. Microbiol. 20: 531-540., (4) Production of L-lactic acid using Lactobacillus delbruekii is described in Stenroos, SL, Linko, YY,
and Linko, P. (1982) Production of L-lactic acid w
ith immobilized Lactobacillus delbruekii. Bacterio
L. Lett. (Biotechnology Letter) 4: 159-164. (5) Lactococcus lactis.
L-lactic acid production using lactis) is described in Ishizaki, A. and
Kobayashi, G. (1990) Computer simulation of L-lacta
te batch fermentation applying the enzyme inactiva
tion scheme. J. Ferment. Bioeng. 70: 139-140.

【0008】以上(1) 〜(5) は乳酸菌を用いたL−乳酸
の製造である。しかし、これらの乳酸菌は栄養要求性が
高く、培地がコスト高となる。乳酸菌を用いた乳酸製造
の培地がコスト高になることは、Boer,J.P.de, Mattos,
M.J.T.de, and Neijssel O.M. (1990) D(-)Lactic acid
production by suspended and aggregated continuous
cultures of Bacillus laevolacticus. Appl. Microbi
ol. Biotechnol. 34:149-153. に記載されている。培地
がコスト高となれば、当然のことながら、製品としての
L−乳酸が高価なものとなる。
The above (1) to (5) are the production of L-lactic acid using lactic acid bacteria. However, these lactic acid bacteria are highly auxotrophic and the cost of the medium is high. High cost of lactic acid production medium using lactic acid bacteria is due to Boer, JPde, Mattos,
MJTde, and Neijssel OM (1990) D (-) Lactic acid
production by suspended and aggregated continuous
cultures of Bacillus laevolacticus. Appl. Microbi
ol. Biotechnol. 34: 149-153. If the cost of the culture medium becomes high, naturally, L-lactic acid as a product becomes expensive.

【0009】そこで、乳酸菌以外の菌を用いたL−乳酸
の製造法も報告されている。例えば、リゾプス オリザ
エ(Rhizopus oryzae) によるL−乳酸の製造が、Tamad
a,M.,Bagum,A.A., and Sadai,S. (1992) Production of
L(+)-lactic acid by immobilized cells of Rhizopus
oryzae with polymer supports prepared by γ rayin
duced polymerization. J. Ferment. Bioeng. 74:379-3
83.に記載されている。しかし、この方法では、発酵時
間が40〜50時間と長く、生産効率が良くない。
Therefore, a method for producing L-lactic acid using bacteria other than lactic acid bacteria has also been reported. For example, the production of L-lactic acid by Rhizopus oryzae has
a, M., Bagum, AA, and Sadai, S. (1992) Production of
L (+)-lactic acid by immobilized cells of Rhizopus
oryzae with polymer supports prepared by γ rayin
duced polymerization. J. Ferment. Bioeng. 74: 379-3
83. However, in this method, the fermentation time is as long as 40 to 50 hours, and the production efficiency is not good.

【0010】また、バチルス ラエボラクティス(Bacil
lus laevolactis)によるD−乳酸製造は、前述の Appl.
Microbiol. Biotechnol. 34:149-153. に報告がある
が、D−乳酸ではしかたない。
In addition, Bacillus Laevolactis
The production of D-lactic acid by lus laevolactis) is described in Appl.
Microbiol. Biotechnol. 34: 149-153. However, it can only be used with D-lactic acid.

【0011】また、バチルス コアグランス(Bacillus
coagulans)によるL−乳酸の製造が、特開昭58−40
093号公報、特公昭60−6200号公報、米国特許
US.5079164号明細書に記載されている。しかしながら、
バチルス コアグランスは、本明細書の実施例で示すが
本発明で用いる菌株に比べ栄養要求性が高く、生産され
るL−乳酸の光学純度は70%未満のものである。ま
た、殺虫性毒素を作るバチルス コアグランス株は知ら
れていない。
In addition, Bacillus coagulans (Bacillus
Production of L-lactic acid by coagulans) is disclosed in JP-A-58-40.
093, Japanese Patent Publication No. 60-6200, US Patent
It is described in US Pat. No. 5,079,164. However,
Bacillus coagulans has higher auxotrophy than the strains used in the present invention as shown in the examples of the present specification, and the optical purity of L-lactic acid produced is less than 70%. Also, no Bacillus coagulans strain that produces an insecticidal toxin is known.

【0012】また、特開平3−27291号公報には、
バチルス コアグランスを用いた乳酸の製造法が記載さ
れている。しかしながら、同号公報では、生産される乳
酸がL−乳酸であることや、その光学純度については全
く言及されていない。さらに、特開平2−76592号
公報にも、その請求項9にバチルス属を用いた乳酸の製
造法が記載されているが、実際にバチルス属を用いてL
−乳酸を生産したことは開示されていない。
Further, Japanese Patent Laid-Open No. 3-27291 discloses that
A method for producing lactic acid using Bacillus coagulans is described. However, the publication does not mention that the lactic acid produced is L-lactic acid or its optical purity. Further, Japanese Patent Application Laid-Open No. 2-76592 describes a method for producing lactic acid using Bacillus genus in claim 9 thereof.
-No production of lactic acid is disclosed.

【0013】[0013]

【発明が解決しようとする課題】本発明の目的は、上記
従来技術の問題点を解決すべく、バチルス属の特定種の
微生物を用いてL−乳酸を高純度で且つ安価に製造する
方法を提供することにある。さらに、本発明の目的は、
殺虫性毒素を生産する能力を有するバチルス属の特定種
の微生物を用いて、高純度L−乳酸と殺虫性毒素とを同
時に生産させ、トータルコストがより下げられた高純度
L−乳酸の製造方法を提供することにある。
SUMMARY OF THE INVENTION An object of the present invention is to provide a method for producing L-lactic acid with high purity and at low cost using a microorganism of a specific species of the genus Bacillus in order to solve the above problems of the prior art. To provide. Further, the object of the present invention is
A method for producing high-purity L-lactic acid in which high-purity L-lactic acid and an insecticidal toxin are simultaneously produced by using a microorganism of a specific species of the genus Bacillus having an ability to produce an insecticidal toxin, and the total cost is further reduced To provide.

【0014】[0014]

【課題を解決するための手段】本発明の高純度L−乳酸
の製造方法は、資化可能な炭素源から光学純度70%以
上のL−乳酸を生産する能力を有する、バチルス・アン
トラシス(Bacillus anthracis)、バチルス・セレウス(B
acillus cereus) 、バチルス・チューリンゲンシス(Bac
illus thuringiensis)、バチルス・ラルバエ(Bacillus
larvae) 、バチルス・レンチモルブス(Bacillus lentim
orbus)、バチルス・ポピラエ(Bacilluspopilliae)およ
びバチルス・スファエリカス(Bacillus sphaericus) か
らなる群から選ばれる少なくとも一種のバチルス属(Bac
illus)の微生物を培養し、この培養物から光学純度70
%以上のL−乳酸を採取することを特徴とするものであ
る。
The method for producing high-purity L-lactic acid according to the present invention has the ability to produce L-lactic acid having an optical purity of 70% or more from an assimilable carbon source, and Bacillus anthracis (Bacillus). anthracis), Bacillus cereus (B
acillus cereus), Bacillus thuringiensis (Bac
illus thuringiensis), Bacillus larvae (Bacillus
larvae), Bacillus lentmorbus (Bacillus lentim)
orbus), Bacillus popilliae and Bacillus sphaericus, and at least one Bacillus genus (Bacillus sphaericus)
illus) microorganism was cultured, and the optical purity of 70% was obtained from this culture.
% Or more of L-lactic acid is collected.

【0015】また、本発明のL−乳酸と殺虫性毒素とを
同時に製造する方法は、資化可能な炭素源から光学純度
70%以上のL−乳酸および殺虫性毒素を生産する能力
を有する、バチルス・チューリンゲンシス(Bacillus th
uringiensis)、バチルス・ラルバエ(Bacillus larvae)
、バチルス・レンチモルブス(Bacillus lentimorbu
s)、バチルス・ポピラエ(Bacillus popilliae)およびバ
チルス・スファエリカス(Bacillus sphaericus) からな
る群から選ばれる少なくとも一種のバチルス属(Bacillu
s)の微生物を培養し、この培養物から光学純度70%以
上のL−乳酸と殺虫性毒素とを採取することを特徴とす
るものである。
The method for simultaneously producing L-lactic acid and insecticidal toxin of the present invention has the ability to produce L-lactic acid and insecticidal toxin having an optical purity of 70% or more from an assimilable carbon source. Bacillus thuringiensis
uringiensis), Bacillus larvae
, Bacillus lentimorbu
s), at least one Bacillus genus (Bacillus popilliae), and Bacillus sphaericus.
The method is characterized in that the microorganism of (s) is cultured and L-lactic acid and an insecticidal toxin having an optical purity of 70% or more are collected from the culture.

【0016】以下、本発明について詳しく説明する。The present invention will be described in detail below.

【0017】本発明において、バチルス属(Bacillus)の
微生物として、バチルス・アントラシス(Bacillus anth
racis)、バチルス・セレウス(Bacillus cereus) 、バチ
ルス・チューリンゲンシス(Bacillus thuringiensis)、
バチルス・ラルバエ(Bacillus larvae) 、バチルス・レ
ンチモルブス(Bacillus lentimorbus)、バチルス・ポピ
ラエ(Bacillus popilliae)またはバチルス・スファエリ
カス(Bacillus sphaericus) を用いる。これらバチルス
属微生物を用いることにより、L−乳酸を光学純度70
%以上の高純度で得ることができる。これら微生物のう
ち、バチルス・アントラシス、バチルス・セレウス、バ
チルス・チューリンゲンシスは、大変近縁であり同定上
の区別が難しいものである。このことは、バージーズ
マニュアル オブ システマティック バクテリオロジ
ーの1113頁にも記載されている。また、これら3種
株は、エッグヨークレシチナーゼ(Egg-yolk lecithinas
e)反応が陽性であることが特徴である。
In the present invention, as a microorganism of the genus Bacillus, Bacillus anthasis is used.
racis), Bacillus cereus (Bacillus cereus), Bacillus thuringiensis (Bacillus thuringiensis),
Bacillus larvae, Bacillus lentimorbus, Bacillus popilliae or Bacillus sphaericus are used. By using these microorganisms belonging to the genus Bacillus, L-lactic acid has an optical purity of 70.
It can be obtained with a high purity of at least%. Among these microorganisms, Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis are very closely related and their identification is difficult to distinguish. This thing is the Burgies
It is also described on page 1113 of the Manual of Systematic Bacteriology. In addition, these three strains are Egg-yolk lecithinas (Egg-yolk lecithinas).
e) The reaction is positive.

【0018】また、本発明において、バチルス属の微生
物として、バチルス・チューリンゲンシス(Bacillus th
uringiensis)、バチルス・ラルバエ(Bacillus larvae)
、バチルス・レンチモルブス(Bacillus lentimorbu
s)、バチルス・ポピラエ(Bacillus popilliae)またはバ
チルス・スファエリカス(Bacillus sphaericus) を用い
ることにより、高純度L−乳酸と共に殺虫性毒素を得る
ことができる。
In the present invention, the Bacillus thuringiensis (Bacillus thuringiensis) is used as the microorganism of the genus Bacillus.
uringiensis), Bacillus larvae
, Bacillus lentimorbu
s), Bacillus popilliae or Bacillus sphaericus, it is possible to obtain an insecticidal toxin together with high-purity L-lactic acid.

【0019】本発明において用いる炭素源としては、グ
ルコース以外に、シュークロース、マルトース、フラク
トース、ラクトース、マンニット、デンプンなど資化可
能な糖であれば限定されることはない。これら糖質の培
地中の濃度は、通常2〜15重量%程度である。
In addition to glucose, the carbon source used in the present invention is not limited as long as it is assimilable sugar such as sucrose, maltose, fructose, lactose, mannitol and starch. The concentration of these sugars in the medium is usually about 2 to 15% by weight.

【0020】また、副原料として、ポリペプトン、チー
ズホエー、コーンスティープリカー、酵母エキスなど安
価な原料を用いることができる。これら副原料の培地中
の濃度は、通常0.1〜2重量%程度である。
As the auxiliary material, inexpensive materials such as polypeptone, cheese whey, corn steep liquor and yeast extract can be used. The concentration of these auxiliary raw materials in the medium is usually about 0.1 to 2% by weight.

【0021】また、培地中には、リン酸カリウム、リン
酸アンモニウム等の無機塩類、苛性ソーダ、塩酸、各種
緩衝液等のpH調整剤、マグネシウム化合物、マンガン
化合物等を含むことができる。
The medium may contain inorganic salts such as potassium phosphate and ammonium phosphate, pH adjusting agents such as caustic soda, hydrochloric acid and various buffers, magnesium compounds, manganese compounds and the like.

【0022】菌体の培養は、通常STR (Stirred Tank Re
actor)で回分式に行なうが、これに限らず、CSTR(Conti
nuous Tank Reactor)で連続的に行なうこともできる。
また、アルギン酸カルシウム、カラギーナン、光硬化性
樹脂等への固定化や膜型リアクター、電解透析型リアク
ターにより生産しても良い。膜型リアクターは、例え
ば、Dialysis(透析型)のものが、Coulman らによる、
Applied EnvironmentalMicrobiology, 1977年34巻、725
-732 頁や、Stieber and Gerhardtによる、Biotechnolo
gy and Bioengineering, 1981年23巻、523-534 頁な
どに記載されている。また、Cross-Flow型の膜型リアク
ターは、Major and Bullによる、Biotechnology and Bi
oengineering, 1989年34巻592-599 頁などに記載されて
いる。
The culture of the bacterial cells is usually performed by STR (Stirred Tank Re
actor) in a batch manner, but not limited to this, CSTR (Conti
nuous Tank Reactor) can also be performed continuously.
Alternatively, it may be produced by immobilization on calcium alginate, carrageenan, a photocurable resin or the like, or by a membrane reactor or an electrolytic dialysis reactor. Membrane reactors are, for example, those of Dialysis (dialysis type) by Coulman et al.
Applied Environmental Microbiology, 1977, 34, 725
-732 and Biotechnolo by Stieber and Gerhardt
gy and Bioengineering, 1981, 23, 523-534. In addition, the Cross-Flow type membrane reactor was developed by Major and Bull in Biotechnology and Bi
oengineering, Vol. 34, 1989, pages 592-599.

【0023】培養のpHおよび温度は、用いる菌体にも
よるが、通常pH6.0〜8.0、温度25〜40℃で
ある。最適条件は、用いる菌体により定められる。
The pH and temperature of the culture depend on the cells used, but are usually pH 6.0-8.0 and temperature 25-40 ° C. Optimal conditions are determined by the bacterial cells used.

【0024】また、本発明において、培養は、好気的条
件下で行うこともできるが、嫌気的条件下で行うことが
好ましい。バチルス属は好気性または通性好気性の微生
物であり、通常、通気等を行うことにより好気的に培養
する。この様な好気的条件では、グルコース等の糖はピ
ルビン酸からクレブス回路を経て代謝される。本発明で
はバチルス属の微生物を嫌気的条件下で培養することに
より、ピルビン酸からより高純度のL−乳酸を、より高
変換率で得ることができる。
In the present invention, the culture can be carried out under aerobic conditions, but it is preferably carried out under anaerobic conditions. The genus Bacillus is an aerobic or facultative aerobic microorganism and is usually aerobically cultured by aeration or the like. Under such aerobic conditions, sugars such as glucose are metabolized from pyruvate through the Krebs cycle. In the present invention, by culturing a bacterium of the genus Bacillus under anaerobic conditions, higher purity L-lactic acid can be obtained from pyruvic acid at a higher conversion rate.

【0025】菌体の培地中への導入は、従来公知のいず
れの方法により行なっても良く、また、生産されたL−
乳酸および場合によっては得られる殺虫性毒素の分離精
製も、従来公知のいずれの方法を用いても良い。
The introduction of the bacterial cells into the medium may be carried out by any conventionally known method, and the produced L-
Separation and purification of lactic acid and the insecticidal toxin obtained in some cases may be performed by any conventionally known method.

【0026】本発明によれば、資化可能な炭素源から光
学純度70%以上のL−乳酸を生産する能力を有するバ
チルス属の微生物、すなわち、バチルス・アントラシ
ス、バチルス・セレウス、バチルス・チューリンゲンシ
ス、バチルス・ラルバエ、バチルス・レンチモルブス、
バチルス・ポピラエまたはバチルス・スファエリカスを
培養するので、光学純度70%以上の高純度でL−乳酸
を製造することができる。また、これらバチルス属の微
生物は、乳酸菌より栄養要求性が低く安価な培地で培養
できるので、より安価にL−乳酸を製造することができ
る。
According to the present invention, a microorganism of the genus Bacillus having the ability to produce L-lactic acid having an optical purity of 70% or more from an assimilable carbon source, that is, Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis. , Bacillus larvae, Bacillus lenthimbus,
Since Bacillus popirae or Bacillus sphaericus is cultured, L-lactic acid can be produced with a high purity of 70% or more in optical purity. In addition, since these Bacillus microorganisms can be cultured in an inexpensive medium that has lower auxotrophy than lactic acid bacteria, L-lactic acid can be produced at a lower cost.

【0027】さらに、本発明において、殺虫性毒素をも
生産する能力を有するバチルス属の微生物、すなわち、
バチルス・チューリンゲンシス、バチルス・ラルバエ、
バチルス・レンチモルブス、バチルス・ポピラエまたは
バチルス・スファエリカスを培養する場合には、光学純
度70%以上のL−乳酸と殺虫性毒素とを同時に製造す
ることができ、トータルコストとしてL−乳酸をより安
価に製造することができる。
Further, in the present invention, a microorganism of the genus Bacillus having the ability to produce insecticidal toxins, that is,
Bacillus thuringiensis, Bacillus larvae,
When Bacillus lentilbus, Bacillus popirae or Bacillus sphaericus is cultured, L-lactic acid having an optical purity of 70% or more and an insecticidal toxin can be produced at the same time, and L-lactic acid can be produced at a lower cost as a total cost. It can be manufactured.

【0028】[0028]

【実施例】次に、実施例により本発明をより具体的に説
明する。
Next, the present invention will be described more specifically with reference to examples.

【0029】[実施例1]バチルス・セレウス(Bacillu
s cereus) JCM 2152 をブレインハートインフュージョ
ン培地(Becton Dickinson社製)で34℃で10時間培
養し、これを種菌とした。この0.1mlづつを2本の
各試験管中の次の組成からなる液体培地10mlに植菌
した。ポリペプトンS(日本製薬製)10g/l、グル
コース20g/l、およびリン酸第2カリウム35g/
l:なお、この培地は1MのHClによって、pH7.
0に調整した。各試験管の口には通気可能な多孔質のシ
リコン栓をし、1本の試験管では嫌気的培養を行ない、
他の1本の試験管では好気的培養を次のように行なっ
た。 <嫌気的培養>試験管をBBK GasPak(Becton
Dickinson社製)に入れ、34℃で10時間、静置培養
した。ガスパック中で行なったので、次の振盪培養より
も嫌気度が高い。 <好気的培養>試験管をBBK GasPak(Becton
Dickinson社製)に入れることなく、34℃で10時
間、120rpmで振盪培養した。
[Example 1] Bacillus cereus
S. cereus) JCM 2152 was cultured in Brain Heart Infusion Medium (Becton Dickinson) at 34 ° C. for 10 hours, and this was used as an inoculum. Each 0.1 ml was inoculated into 10 ml of a liquid medium having the following composition in two test tubes. Polypeptone S (Nippon Pharmaceutical Co., Ltd.) 10 g / l, glucose 20 g / l, and dipotassium phosphate 35 g / l
1: The medium had a pH of 7.
Adjusted to zero. The mouth of each test tube has a porous silicon stopper that can be vented, and one test tube is used for anaerobic culture.
Aerobic culture was performed in the other test tube as follows. <Anaerobic culture> Use test tubes with BBK GasPak (Becton
Dickinson) and statically cultured at 34 ° C. for 10 hours. Since it was performed in a gas pack, it is more anaerobic than the next shake culture. <Aerobic culture> Test tubes with BBK GasPak (Becton
The culture was carried out at 34 ° C. for 10 hours with shaking at 120 rpm without being placed in Dickinson.

【0030】培養後、乳酸生成量(g/l)、消費グル
コース量(g/l)、変換率(%)および光学純度
(%)を以下のようにして求めた。
After culturing, the amount of lactic acid produced (g / l), the amount of glucose consumed (g / l), the conversion rate (%) and the optical purity (%) were determined as follows.

【0031】<乳酸生成量および消費グルコース量>乳
酸生成量および消費グルコース量は、それぞれ培養液中
の乳酸濃度(g/l)および消費グルコース量(g/
l)として、高速液体クロマトグラフィー(HPLC)
により次の条件で定量した。なお、乳酸生成量は、L−
体及びD−体の合計量である。HPLC;(島津製作所
製、LC−6A)、検出器;示差屈折率計(RID−6
A、島津製作所製)、カラム;Shim-pack SCR-101H(島
津製作所製)、カラム温度;60℃、溶離液;2.5m
molの過塩素酸水溶液、流速;0.9ml/min。
<Amount of lactic acid produced and amount of glucose consumed> The amount of lactic acid produced and the amount of glucose consumed are the lactic acid concentration (g / l) and the amount of glucose consumed (g / l) in the culture solution, respectively.
l) as high performance liquid chromatography (HPLC)
Was quantified under the following conditions. The amount of lactic acid produced was L-
The total amount of body and D-body. HPLC; (manufactured by Shimadzu Corporation, LC-6A), detector; differential refractometer (RID-6)
A, Shimadzu), column: Shim-pack SCR-101H (Shimadzu), column temperature: 60 ° C, eluent: 2.5 m
Molar perchloric acid aqueous solution, flow rate; 0.9 ml / min.

【0032】<変換率>変換率は、 変換率(%)=(乳酸生成量(g/l) /消費グルコース量
(g/l) )×100 で計算される。ここで、乳酸生成量は、L−体及びD−
体の合計量である。
<Conversion rate> The conversion rate is the conversion rate (%) = (lactic acid production amount (g / l) / glucose consumption amount)
(g / l)) × 100. Here, the production amount of lactic acid is L-form and D-form.
The total amount of body.

【0033】<光学純度>L−乳酸の光学純度は次式で
計算される: 光学純度(%)=100×(L−D)/(L+D) ここで、LはL−乳酸の濃度、DはD−乳酸の濃度を表
す。培養液サンプルをUF膜(UFPI,ミリポア)で
濾過して、分子量5000以上の分子をカットした。こ
れを高速液体クロマトグラフィーにより測定し、培養液
中のL−乳酸とD−乳酸の濃度を定量した。HPLC;
(島津製作所製、LC−6A)、検出器;分光計(島津
製作所製、SPD−6AV)、カラム;CRS10W
(三菱化成製)、カラム温度;30℃、検出波長;25
4nm、溶離液;2mMのCuSO4 、流速;0.5m
l/min。
<Optical Purity> The optical purity of L-lactic acid is calculated by the following formula: Optical purity (%) = 100 × (LD) / (L + D) where L is the concentration of L-lactic acid and D Represents the concentration of D-lactic acid. The culture solution sample was filtered through a UF membrane (UFPI, Millipore) to cut off molecules having a molecular weight of 5000 or more. This was measured by high performance liquid chromatography to quantify the concentrations of L-lactic acid and D-lactic acid in the culture solution. HPLC;
(Shimadzu Corporation, LC-6A), Detector; Spectrometer (Shimadzu Corporation, SPD-6AV), Column; CRS10W
(Manufactured by Mitsubishi Kasei), column temperature; 30 ° C, detection wavelength; 25
4 nm, eluent; 2 mM CuSO 4 , flow rate; 0.5 m
l / min.

【0034】[実施例2]実施例1のバチルス・セレウ
ス(Bacillus cereus) JCM 2152に代えて、菌株としてバ
チルス・チューリンゲンシス(Bacillus thuringiensis)
subsp.kurustaki ATCC 33679を用いた以外は、実施例
1と同様の操作で培養を行ない、乳酸生成量(g/
l)、消費グルコース量(g/l)、変換率(%)およ
び光学純度(%)を求めた。
Example 2 In place of Bacillus cereus JCM 2152 of Example 1, Bacillus thuringiensis was used as a strain.
Culture was performed in the same manner as in Example 1 except that subsp. kurustaki ATCC 33679 was used to produce lactic acid (g / g).
1), glucose consumption (g / l), conversion rate (%) and optical purity (%) were determined.

【0035】[比較例1]実施例1のバチルス・セレウ
ス(Bacillus cereus) JCM 2152に代えて、菌株としてバ
チルス・コアグランス(Bacillus coagulans) JCM 2257
を用いた以外は、実施例1と同様の操作で培養を行な
い、乳酸生成量(g/l)、消費グルコース量(g/
l)、変換率(%)および光学純度(%)を求めた。
[Comparative Example 1] In place of Bacillus cereus JCM 2152 of Example 1, Bacillus coagulans JCM 2257 was used as a strain.
Culturing was performed in the same manner as in Example 1 except that the amount of lactic acid produced (g / l) and the amount of glucose consumed (g / g) were used.
l), conversion rate (%) and optical purity (%) were determined.

【0036】[比較例2]実施例1のバチルス・セレウ
ス(Bacillus cereus) JCM 2152に代えて、菌株としてバ
チルス・ズブチリス(Bacillus subtilis) JCM 1465を用
いた以外は、実施例1と同様の操作で培養を行ない、乳
酸生成量(g/l)、消費グルコース量(g/l)、変
換率(%)および光学純度(%)を求めた。
[Comparative Example 2] The same procedure as in Example 1 was repeated except that Bacillus subtilis JCM 1465 was used as the strain instead of Bacillus cereus JCM 2152 of Example 1. After culturing, the amount of lactic acid produced (g / l), the amount of glucose consumed (g / l), the conversion rate (%) and the optical purity (%) were determined.

【0037】実施例1〜2、比較例1〜2の結果を表1
に示す。
The results of Examples 1 and 2 and Comparative Examples 1 and 2 are shown in Table 1.
Shown in

【表1】 [Table 1]

【0038】表1より、菌株としてバチルス・セレウ
ス、バチルス・チューリンゲンシスを用いた場合は、高
変換率で、しかも高い光学純度でL−乳酸が生成した。
また、好気的培養に比べ嫌気的培養の方が、高い変換率
と高い光学純度が得られた。一方、菌株としてバチルス
・コアグランスを用いた場合は、好気的培養した場合で
も乳酸生成量は少なく、光学純度も70%に満たないも
のであった。嫌気的培養の場合は、乳酸生成が認められ
なかった。菌株としてバチルス・ズブチリスを用いた場
合は、嫌気的及び好気的条件でいずれも乳酸を生成した
が、その濃度及び変換率はそれぞれ、0.1g/l、2
5.0%、3.7g/l、49.3%と実用に耐えるも
のではなかった。
From Table 1, when Bacillus cereus and Bacillus thuringiensis were used as the strains, L-lactic acid was produced with a high conversion rate and a high optical purity.
In addition, the conversion rate and the optical purity were higher in the anaerobic culture than in the aerobic culture. On the other hand, when Bacillus coagulans was used as the strain, the amount of lactic acid produced was small even under aerobic culture, and the optical purity was less than 70%. No lactic acid production was observed in the case of anaerobic culture. When Bacillus subtilis was used as the strain, lactic acid was produced under both anaerobic and aerobic conditions, but the concentration and conversion rate were 0.1 g / l and 2%, respectively.
The results were 5.0%, 3.7 g / l, and 49.3%, which were not practical.

【0039】また、これらの結果で注目すべきは、グル
コース以外の副原料としてポリペプトンSで良いという
ことであり、このことは、乳酸菌ではまずあり得ない。
つまり、これらバチルス・セレウス、バチルス・チュー
リンゲンシスの菌株が乳酸菌やバチルス・コアグランス
よりも栄養要求性が低く、培地を選ばないということで
あり、より安価な培地で高純度のL−乳酸を生産できる
ことが明かとなった。
Also noteworthy in these results is that polypeptone S is good as an auxiliary material other than glucose, which is unlikely in lactic acid bacteria.
That is, these Bacillus cereus and Bacillus thuringiensis strains have lower auxotrophy than lactic acid bacteria and Bacillus coagulans and do not select a medium, and can produce high-purity L-lactic acid in a cheaper medium. Became clear.

【0040】[実施例3]バチルス・チューリンゲンシ
ス(Bacillus thuringiensis) subsp.kurustakiATCC 33
679を、培地はポリペプトンS;10g/l、リン酸ア
ンモニウム;5g/l、およびグルコース100g/l
からなる培地で培養した。培養は500mlの培養器
(培養液量500ml)を用い、30℃、60rpmで
攪拌を行い、6M苛性ソーダによりpHを7.0に保っ
た。また、嫌気的条件を保つため30ml/minで窒
素ガスを通気し、30℃で15時間培養した。培養液の
乳酸濃度は98g/lであり、光学純度は99.5%で
あった。この培養液から遠心分離(20,000G、1
5分)により菌体を集菌したところ、湿重量にして30
gの菌体が得られ、位相差顕微鏡で観察したところ、
0.6×2μの紡錘形結晶が観察された。菌体を150
wの超音波破砕機を用いて10分間で破砕し、これをア
メリカシロヒトリの幼虫20匹に飼料として与えたとこ
ろ、7匹が1時間以内に、10匹が1時間から2時間以
内に、3匹が2時間から5時間以内に死んだ。このよう
に、菌株としてバチルス・チューリンゲンシスを用いた
場合は、高変換率で、しかも高い光学純度でL−乳酸が
得られると共に、殺虫性毒素が同時に得られた。従っ
て、トータルコストとしてL−乳酸をより安価に製造で
きることが明かとなった。
[Example 3] Bacillus thuringiensis subsp. Kurustaki ATCC 33
679, the medium is polypeptone S; 10 g / l, ammonium phosphate; 5 g / l, and glucose 100 g / l
It was cultured in a medium consisting of The culture was performed using a 500 ml incubator (500 ml of culture solution), stirring at 30 ° C. and 60 rpm, and the pH was maintained at 7.0 with 6M caustic soda. Further, in order to maintain the anaerobic condition, nitrogen gas was aerated at 30 ml / min, and the cells were cultured at 30 ° C. for 15 hours. The lactic acid concentration of the culture broth was 98 g / l, and the optical purity was 99.5%. Centrifugation (20,000 G, 1
After collecting the bacterial cells for 5 minutes, the wet weight was 30
g of cells were obtained and observed with a phase contrast microscope,
0.6 × 2μ spindle-shaped crystals were observed. 150 cells
It was crushed for 10 minutes using an ultrasonic crusher of w, and this was fed to 20 larvae of the American white-hit, as a feed. 7 animals within 1 hour, 10 animals within 1 to 2 hours The animal died within 2 to 5 hours. Thus, when Bacillus thuringiensis was used as the strain, L-lactic acid was obtained with a high conversion rate and a high optical purity, and an insecticidal toxin was obtained at the same time. Therefore, it became clear that L-lactic acid can be produced at a lower cost as a total cost.

【0041】[0041]

【発明の効果】本発明の方法によれば、上述のように、
非常に高い光学純度のL−乳酸を安価に製造することが
できる。さらに好ましい本発明の方法によれば、L−乳
酸と共に殺虫性毒素を同時に製造することができ、トー
タルコストとして高い光学純度のL−乳酸をより安価に
製造することができる。このように、本発明の方法は、
従来の微生物を用いたL−乳酸製造法に比べ、非常に有
用なものである。
According to the method of the present invention, as described above,
L-lactic acid with very high optical purity can be produced at low cost. According to the more preferred method of the present invention, an insecticidal toxin can be simultaneously produced together with L-lactic acid, and L-lactic acid with high optical purity as a total cost can be produced at a lower cost. Thus, the method of the present invention is
It is very useful as compared with conventional L-lactic acid production methods using microorganisms.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 (C12P 7/56 C12R 1:07) (C12P 7/56 C12R 1:085) (C12P 1/04 C12R 1:07) (C12P 21/02 C12R 1:07) (C12N 1/20 C12R 1:07) C07M 7:00 ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification number Office reference number FI technical display location (C12P 7/56 C12R 1:07) (C12P 7/56 C12R 1: 085) (C12P 1/04 C12R 1:07) (C12P 21/02 C12R 1:07) (C12N 1/20 C12R 1:07) C07M 7:00

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 資化可能な炭素源から光学純度70%以
上のL−乳酸を生産する能力を有する、バチルス・アン
トラシス(Bacillus anthracis)、バチルス・セレウス(B
acillus cereus) 、バチルス・チューリンゲンシス(Bac
illus thuringiensis)、バチルス・ラルバエ(Bacillus
larvae) 、バチルス・レンチモルブス(Bacillus lentim
orbus)、バチルス・ポピラエ(Bacillus popilliae)およ
びバチルス・スファエリカス(Bacillus sphaericus) か
らなる群から選ばれる少なくとも一種のバチルス属(Bac
illus)の微生物を培養し、この培養物から光学純度70
%以上のL−乳酸を採取することを特徴とする、L−乳
酸の製造方法。
1. A Bacillus anthracis or Bacillus cereus (B) having an ability to produce L-lactic acid having an optical purity of 70% or more from an assimilable carbon source.
acillus cereus), Bacillus thuringiensis (Bac
illus thuringiensis), Bacillus larvae (Bacillus
larvae), Bacillus lentmorbus (Bacillus lentim)
orbus), Bacillus popilliae and Bacillus sphaericus, and at least one Bacillus genus (Bacillus sphaericus)
illus) microorganism was cultured, and the optical purity of 70% was obtained from this culture.
% Or more L-lactic acid is collected, The manufacturing method of L-lactic acid characterized by the above-mentioned.
【請求項2】 資化可能な炭素源から光学純度70%以
上のL−乳酸および殺虫性毒素を生産する能力を有す
る、バチルス・チューリンゲンシス(Bacillusthuringie
nsis)、バチルス・ラルバエ(Bacillus larvae) 、バチ
ルス・レンチモルブス(Bacillus lentimorbus)、バチル
ス・ポピラエ(Bacillus popilliae)およびバチルス・ス
ファエリカス(Bacillus sphaericus) からなる群から選
ばれる少なくとも一種のバチルス属(Bacillus)の微生物
を培養し、この培養物から光学純度70%以上のL−乳
酸と殺虫性毒素とを採取することを特徴とする、L−乳
酸と殺虫性毒素とを同時に製造する方法。
2. Bacillus thuringiensis having the ability to produce L-lactic acid and an insecticidal toxin with an optical purity of 70% or more from an assimilable carbon source.
nsis), Bacillus larvae, Bacillus lentimorbus, Bacillus popilliae, and Bacillus sphaericus, at least one microorganism belonging to the genus Bacillus. A method for producing L-lactic acid and an insecticidal toxin at the same time, which comprises culturing L. lactic acid and an insecticidal toxin having an optical purity of 70% or more from the culture.
【請求項3】 嫌気的条件下でバチルス属(Bacillus)の
微生物を培養することを特徴とする、請求項1または2
項に記載の方法。
3. The method according to claim 1, wherein the microorganism of the genus Bacillus is cultured under anaerobic conditions.
The method described in the section.
JP28066095A 1995-10-27 1995-10-27 Method for producing high purity L-lactic acid using Bacillus microorganism Expired - Fee Related JP3736691B2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP28066095A JP3736691B2 (en) 1995-10-27 1995-10-27 Method for producing high purity L-lactic acid using Bacillus microorganism
BR9605262A BR9605262A (en) 1995-10-27 1996-10-25 Method for the production of lactic acid with high optical purity using bacillus strains
US08/738,289 US5801025A (en) 1995-10-27 1996-10-25 Method for producing L-lactic acid with high optical purity using bacillus strains
CN96121927A CN1075111C (en) 1995-10-27 1996-10-26 Method for generating high-optical-purity L-lactic acid using Bacillus strain
EP96117295A EP0770684B1 (en) 1995-10-27 1996-10-28 Method for producing L-lactic acid with high optical purity using bacillus strains
ES96117295T ES2188708T3 (en) 1995-10-27 1996-10-28 L-LACTIC ACID PRODUCTION METHOD WITH HIGH OPTICAL PURITY USING BACILLUS STRAINS.
CN00133110A CN1308128A (en) 1995-10-27 2000-09-30 Method of producing high optical-purity L-lactic acid with Bacillus strain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28066095A JP3736691B2 (en) 1995-10-27 1995-10-27 Method for producing high purity L-lactic acid using Bacillus microorganism

Publications (2)

Publication Number Publication Date
JPH09121877A true JPH09121877A (en) 1997-05-13
JP3736691B2 JP3736691B2 (en) 2006-01-18

Family

ID=17628161

Family Applications (1)

Application Number Title Priority Date Filing Date
JP28066095A Expired - Fee Related JP3736691B2 (en) 1995-10-27 1995-10-27 Method for producing high purity L-lactic acid using Bacillus microorganism

Country Status (1)

Country Link
JP (1) JP3736691B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003088392A (en) * 2001-09-14 2003-03-25 Toray Ind Inc Method for producing d-lactic acid
WO2008065749A1 (en) * 2006-11-30 2008-06-05 Seiko Sato Plant-derived natural biodegradable material
JP5811535B2 (en) * 2008-12-26 2015-11-11 東レ株式会社 Method for producing lactic acid and polylactic acid

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110408672B (en) * 2019-08-06 2020-11-24 山东寿光巨能金玉米开发有限公司 Method for extracting D-lactic acid from D-lactic acid waste liquid

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003088392A (en) * 2001-09-14 2003-03-25 Toray Ind Inc Method for producing d-lactic acid
JP4742475B2 (en) * 2001-09-14 2011-08-10 東レ株式会社 Method for producing D-lactic acid
WO2008065749A1 (en) * 2006-11-30 2008-06-05 Seiko Sato Plant-derived natural biodegradable material
US8349418B2 (en) 2006-11-30 2013-01-08 Seiko Sato Plant-derived natural biodegradable material
JP5811535B2 (en) * 2008-12-26 2015-11-11 東レ株式会社 Method for producing lactic acid and polylactic acid
US10683254B2 (en) 2008-12-26 2020-06-16 Toray Industries, Inc. Method for producing lactic acid and method for producing polylactic acid
US11597694B2 (en) 2008-12-26 2023-03-07 Toray Industries, Inc. Method for producing lactic acid and method for producing polylactic acid

Also Published As

Publication number Publication date
JP3736691B2 (en) 2006-01-18

Similar Documents

Publication Publication Date Title
Ohara et al. L-Lactic acid production by Bacillus sp. in anaerobic and aerobic culture
Tashiro et al. Continuous d-lactic acid production by a novelthermotolerant Lactobacillus delbrueckii subsp. lactis QU 41
KR100714364B1 (en) Method for producing polylactic acid and corresponding device
JP4318638B2 (en) Fermentation process using specific oxygen uptake rate as process control.
AU2005257068B2 (en) Production of polylactic acid (PLA) from renewable feedstocks
US5801025A (en) Method for producing L-lactic acid with high optical purity using bacillus strains
JP4067970B2 (en) Thermophilic microorganism Bacillus coagulans SIM-TDSM14043 for producing L (+)-lactate from fermentable sugars and mixtures thereof
WO2009006909A1 (en) Process for producing organic acids by continuous fermentation
Tsai et al. Strain screening and development for industrial lactic acid fermentation
US20200056212A1 (en) Fermentation process for producing d-lactic acid or its salts
JP3736691B2 (en) Method for producing high purity L-lactic acid using Bacillus microorganism
WO2010103548A2 (en) Improved method for producing lactic acid and derivative thereof
EP0839209B1 (en) Method for preparing pure lactic acid
JP5217736B2 (en) Method for producing D-lactic acid
US6022537A (en) Bacterial strains of the genus Bacillus, closely phenotypically related to the genus Lactobacillus, culture method and use
JP3682679B2 (en) High-purity L-lactic acid producing bacterium and method for producing L-lactic acid
JP4742475B2 (en) Method for producing D-lactic acid
JP6621549B2 (en) Bacillus aerolacticus for producing L-lactic acid or a salt thereof from various carbon sources
Nath et al. Enhanced production of 3-hydroxybutyric acid (3-HB) by in vivo depolymerization of polyhydroxybutyric acid in 3-HB dehydrogenase mutants of Methylobaterium sp. ZP24
JP4269416B2 (en) Process for producing α-halo-α, β-saturated carbonyl compound
US6238895B1 (en) Production of aspartic and malic acids with microbacterium
EP1570050B1 (en) Bacterial strains of genus exiguobacterium, culture method and uses
Mirdamadi et al. Lactic acid production by Lactobacillus strains
WO1992018637A1 (en) Method for the production of d-gluconic acid
JP2004059789A (en) Biodegradable polymer, new microorganism producing the same, method for producing the same, biodegradable random copolymer and method for isolating the copolymer

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050715

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050909

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20051007

A61 First payment of annual fees (during grant procedure)

Effective date: 20051020

Free format text: JAPANESE INTERMEDIATE CODE: A61

R150 Certificate of patent (=grant) or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 3

Free format text: PAYMENT UNTIL: 20081104

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 4

Free format text: PAYMENT UNTIL: 20091104

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101104

Year of fee payment: 5

LAPS Cancellation because of no payment of annual fees